Karyopharm Therapeutics

Karyopharm Therapeutics Inc

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical

Model

01Company Overview

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on pioneering novel cancer therapies, particularly through the use of Selective Inhibitor of Nuclear Export (SINE) technology.

02Backed By1 investor

ACAvoro Capital Advisors→

03Similar Companies

OP

Is this your company? Claim your profile

ORIC Pharmaceuticals

Biotech & Life Sciences

→

AT

Avenzo Therapeutics

Biotech & Life Sciences

→

BA

BerGenBio ASA

Biotech & Life Sciences

→

IT

Immune-Onc Therapeutics

Biotech & Life Sciences

→

GT

G1 Therapeutics

Biotech & Life Sciences

→

04Startup DNA

11

signals

Sectors
Business Model
Technology